Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$2.37M Buy
49,392
+8,019
+19% +$380K 0.04% 676
2017
Q3
$1.91M Buy
41,373
+6,136
+17% +$266K 0.03% 686
2017
Q2
$1.56M Sell
35,237
-12,043
-25% -$506K 0.03% 673
2017
Q1
$1.94M Sell
47,280
-112,866
-70% -$4.71M 0.04% 633
2016
Q4
$6.58M Buy
160,146
+20,071
+14% +$738K 0.2% 167
2016
Q3
$4.56M Buy
+140,075
New +$4.4M 0.17% 188
2016
Q1
Sell
-7,665
Closed -$248K 820
2015
Q4
$248K Sell
7,665
-11,610
-60% -$370K 0.02% 662
2015
Q3
$570K Sell
19,275
-176,963
-90% -$5.42M 0.09% 324
2015
Q2
$6.05M Buy
+196,238
New +$5.67M 0.24% 111
2015
Q1
Sell
-18,127
Closed -$491K 837
2014
Q4
$491K Sell
18,127
-76,595
-81% -$1.93M 0.03% 653
2014
Q3
$2.24M Buy
+94,722
New +$2.27M 0.17% 247

Other funds holding SNV

AHL Partners's SNV Position: Q4 2017 in Review

AHL Partners increased its Synovus (SNV) stake by 19% in Q4 2017, buying an estimated $380K and bringing the position to 49,392 shares worth $2.37M. The position accounts for 0.04% of the portfolio, ranked #676.

AHL Partners first reported a position in SNV in Q3 2014 and has held it in 11 quarters since. The position peaked at $6.58M in Q4 2016. 333 funds tracked by Wall St. Rank hold SNV as of Q4 2017.

  • AHL Partners held 49,392 shares of Synovus worth $2.37M as of Q4 2017.
  • AHL Partners bought 8,019 Synovus shares in Q4 2017, an estimated $380K.
  • Synovus made up 0.04% of AHL Partners's portfolio in Q4 2017, its #676 holding.
  • AHL Partners first reported a position in Synovus in Q3 2014 and has held it in 11 quarters since.
  • AHL Partners's Synovus position peaked at $6.58M in Q4 2016.
  • 333 funds tracked by Wall St. Rank held Synovus as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.